Profile

Dr. Anthony Culyer, PhD

University of York

Contact Details

University of York
Ribbons

Dr. Anthony Culyer, PhD


University of York

Bio

Recent articles and books

Books

E Tompa, A J Culyer, R Dolinschi (Eds.) Economic Evaluation of Interventions for Occupational Health and safety: Developing Good Practice, Oxford: Oxford University Press, 2008, pp. xvi + 295.

A J Culyer, Editor-in-Chief, Encyclopedia of Health Economics, Elsevier, on-line, 2014.

A J Culyer, The Dictionary of Health Economics, 3rd edition, Cheltenham: Edward Elgar, 2014.

The Humble Economist: Tony Culyer on Health, Health Care and Social Decision Making, (Eds. Richard Cookson and Karl Claxton), London and York: Office of Health Economics and University of York, 2012, pp. xiii + 382.

A J Culyer, C Podhisita, B Santatiwongchai, A Star in the East: A Short History of HITAP, Bangkok: Amarin, 2016.

Articles

A J Culyer, “Are there really ten good arguments for a societal perspective in the economic evaluations of medical innovations?” in A J Culyer and G Kobelt (eds.) Portrait of a Health Economist: Festschrift in Honour of Bengt Jönsson, Lund: Institute of Health Economics, 2014, 33-38.

A J Culyer, “Where are the limits of cost-effectiveness analysis and health technology assessment?” Journal of the Medical Association of Thailand, 2014; 97 (Suppl. 5): S1-S2.

A J Culyer, “Four issues with cost-effectiveness analysis: a view from the side-lines”. In Health Technology Assessment and Health Policy Today: A Multifaceted View of Their Unstable Crossroads, Madrid: Springer, 2014, 1-18.

M Paulden, James F O’Mahony, A J Culyer, C McCabe, “Some inconsistencies in NICE’s consideration of social values”, PharmacoEconomics, 2014, 32: 1043-53.

M Paulden, James F O’Mahony, A J Culyer, C McCabe, “Objectivity and Equity: Clarity Required. A Response to Hill and Olson”, PharmacoEconomics, 2014, DOI: 10.1007/s40273-014-0239-6.

D Husereau, A J Culyer, P Neumann, P Jacobs, “How do economic evaluations inform health policy decisions for treatment and prevention in Canada and the United States?”, Applied Health Economics and Health Policy, 2014, 1-7. DOI: 10.1007/s40258-014-0133-6.

K Claxton, M Sculpher, S Palmer and A J Culyer, “Causes for concern: is NICE failing to uphold its responsibilities to all NHS patients?” Health Economics, 2015, 24: 1–7.

A J Culyer, “Why do/should we do economic evaluation?” Value in Health Spotlight, 2015, 1: 8-10.

P A Paprica, A J Culyer, A G Eshag, J Peffer, G A Sandoval, “From talk to action: policy stakeholders, appropriateness, and selective disinvestment”, International Journal of Technology Assessment in Health Care, 2015, 31: 1-5.

C. McCabe, M. Paulden, J.F. O’Mahony, R. Edlin, A.J. Culyer, “Life at a premium: considering an end-of-life premium in value-based reimbursement”, Value in Health, 2015, 18, A6-A7.

K J Hofman, K Chalkidou, D Tantivess, A J Culyer, “National Health Insurance in South Africa: Relevance of a national Priority-Setting Agency, South African Medical Journal, 2015, 105: 739-40 (editorial).